SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-000972
Filing Date
2020-01-03
Accepted
2020-01-03 17:15:39
Documents
2
Period of Report
2020-01-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm201085d1_3.html 3  
1 OWNERSHIP DOCUMENT tm201085d1_3.xml 3 2165
2 EXHIBIT 24 tm201085d1_ex24.htm EX-24 5219
  Complete submission text file 0001104659-20-000972.txt   9015
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CYMABAY THERAPEUTICS, INC. 7575 GATEWAY BLVD., SUITE 110 NEWARK CA 94560
Business Address
Boudes Pol F (Reporting) CIK: 0001454771 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33357 | Film No.: 20506714